Search Results 231-240 of 37993 for Two-phase

  1. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors - Mayo Clinic

    Phase 2 is designed to evaluate the safety and efficacy of \[177Lu\]Lu FAP 2286 as monotherapy in participants with pancreatic ductal adenocarcinoma (PDAC), non ...

  2. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.

  3. Surgery remains an important treatment option for pediatric inflammatory bowel disease (IBD) - Mayo Clinic

    Stage 2. After about three months, the surgeon reconnects the cut ends of the small intestine so waste can pass as usual. For patients who have issues with ...

  4. Study To Evaluate Efficacy And Safety Of ONL1204 In Patients With GA Associated With AMD - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Breast cancer staging - Mayo Clinic

    Two people with the same size cancer could have different stages. Here's a ... A stage 3 breast cancer is often more difficult to treat than a stage 1 or stage 2 ...

  6. Neuroendocrine tumors - Stages - Mayo Clinic

    A stage 1 pancreatic neuroendocrine tumor is small and only in the pancreas. The cancer is less than 2 centimeters (about 3/4 inch) at its widest point. Stage 2 ...

  7. Neurology - Clinical trials

    ... Phase 2b clinical trial. Arizona Alzheimer's ... There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades ...

  8. Neurology - Clinical trials - Mayo Clinic

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  9. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

    LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High ...

  10. Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of and to define the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D); and ...